Differential Patterns of IgG Subclass Responses to


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 30 10 2018
accepted: 19 02 2019
entrez: 2 4 2019
pubmed: 2 4 2019
medline: 25 8 2020
Statut: epublish

Résumé

Naturally acquired immunity (NAI) to

Identifiants

pubmed: 30930896
doi: 10.3389/fimmu.2019.00439
pmc: PMC6428712
doi:

Substances chimiques

Antigens, Protozoan 0
Immunoglobulin G 0
Malaria Vaccines 0

Types de publication

Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

439

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI095789
Pays : United States

Références

Infect Immun. 2000 Mar;68(3):1252-8
pubmed: 10678934
Infect Immun. 2000 May;68(5):2617-20
pubmed: 10768952
Nat Med. 2000 Jun;6(6):689-92
pubmed: 10835687
Eur J Immunol. 2001 Feb;31(2):539-50
pubmed: 11180119
Parasite Immunol. 2002 Feb;24(2):77-82
pubmed: 11874562
Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:229-34
pubmed: 1343695
Nature. 1961 Nov 25;192:733-7
pubmed: 13880318
Infect Immun. 1992 Apr;60(4):1473-81
pubmed: 1548071
Lancet. 2004 Oct 16-22;364(9443):1411-20
pubmed: 15488216
Infect Immun. 2004 Nov;72(11):6492-502
pubmed: 15501780
Malar J. 2005 Sep 29;4:48
pubmed: 16194274
Infect Immun. 2006 Jan;74(1):257-64
pubmed: 16368979
Microbes Infect. 2006 Apr;8(5):1269-76
pubmed: 16679041
Res Immunol. 1990 Jul-Aug;141(6):529-42
pubmed: 1704637
PLoS Med. 2007 Nov 13;4(11):e320
pubmed: 18001147
J Immunol. 1991 Aug 15;147(4):1338-43
pubmed: 1831223
J Infect Dis. 2008 Jul 1;198(1):134-42
pubmed: 18471084
Malar J. 2008 Sep 24;7:186
pubmed: 18816374
Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents
pubmed: 19136431
Infect Immun. 2009 Mar;77(3):1165-74
pubmed: 19139189
Clin Exp Allergy. 2009 Apr;39(4):469-77
pubmed: 19222496
PLoS One. 2009;4(4):e5165
pubmed: 19365567
J Infect Dis. 2009 Aug 1;200(3):329-36
pubmed: 19569964
Clin Infect Dis. 2010 Oct 15;51(8):e50-60
pubmed: 20843207
J Immunol. 2010 Nov 15;185(10):6157-67
pubmed: 20962255
Vaccine. 2011 Aug 11;29(35):6059-67
pubmed: 21443960
N Engl J Med. 2011 Nov 17;365(20):1863-75
pubmed: 22007715
PLoS One. 2011;6(10):e25779
pubmed: 22022448
Clin Vaccine Immunol. 2012 Feb;19(2):157-66
pubmed: 22169088
Clin Dev Immunol. 2012;2012:985646
pubmed: 22235228
Nat Rev Drug Discov. 2012 Mar 30;11(4):311-31
pubmed: 22460124
Blood. 2012 Jun 14;119(24):5640-9
pubmed: 22535666
N Engl J Med. 2012 Dec 13;367(24):2284-95
pubmed: 23136909
Front Immunol. 2013 Aug 09;4:235
pubmed: 23950757
PLoS One. 2013 Sep 09;8(9):e74627
pubmed: 24040299
J Infect Dis. 2014 Mar 1;209(5):789-98
pubmed: 24133188
BMC Infect Dis. 2013 Dec 28;13:608
pubmed: 24373342
BMC Med. 2014 Jul 01;12:108
pubmed: 24980799
PLoS One. 2014 Jul 21;9(7):e101737
pubmed: 25047634
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
Infect Immun. 2015 Feb;83(2):646-60
pubmed: 25422270
Mol Cell Proteomics. 2015 Mar;14(3):519-31
pubmed: 25547414
Immunity. 2015 Mar 17;42(3):580-90
pubmed: 25786180
Lancet. 2015 Jul 4;386(9988):31-45
pubmed: 25913272
Lancet Infect Dis. 2015 Dec;15(12):1450-8
pubmed: 26342424
Vaccine. 2015 Dec 22;33(52):7452-61
pubmed: 26469720
FEMS Microbiol Rev. 2016 May;40(3):343-72
pubmed: 26833236
Infect Immun. 2016 Jul 21;84(8):2175-2184
pubmed: 27185785
Malar J. 2016 May 31;15:301
pubmed: 27245446
Sci Rep. 2016 Sep 08;6:33094
pubmed: 27604417
Malar J. 2017 Apr 11;16(1):145
pubmed: 28399920
Clin Infect Dis. 2017 Sep 1;65(5):746-755
pubmed: 28505356
Malar J. 2017 Aug 5;16(1):314
pubmed: 28779755
Sci Rep. 2017 Aug 11;7(1):7998
pubmed: 28801554
PLoS Med. 2017 Oct 9;14(10):e1002403
pubmed: 28991911
Front Immunol. 2017 Oct 13;8:1294
pubmed: 29163461
J Immunol Methods. 2018 Apr;455:41-54
pubmed: 29397157
J Infect Dis. 2018 Aug 14;218(6):956-965
pubmed: 29733355
Malar J. 2018 Jun 1;17(1):219
pubmed: 29859096
PLoS One. 2018 Jul 2;13(7):e0199278
pubmed: 29966018
BMC Med. 2018 Oct 31;16(1):197
pubmed: 30376866
Infect Immun. 1986 Mar;51(3):859-64
pubmed: 3512436
Infect Immun. 1995 Nov;63(11):4382-8
pubmed: 7591074
Blood. 1994 Sep 1;84(5):1594-602
pubmed: 8068948
Infect Immun. 1997 Mar;65(3):1098-100
pubmed: 9038322

Auteurs

Carlota Dobaño (C)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.

Rebeca Santano (R)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Marta Vidal (M)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Alfons Jiménez (A)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Spanish Consortium for Research in Epidemiology and Public Health (CIBERESP), Barcelona, Spain.

Chenjerai Jairoce (C)

Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.

Itziar Ubillos (I)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

David Dosoo (D)

Kintampo Health Research Centre, Kintampo, Ghana.

Ruth Aguilar (R)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Nana Aba Williams (NA)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Núria Díez-Padrisa (N)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Aintzane Ayestaran (A)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Clarissa Valim (C)

Department of Osteopathic Medical Specialties, Michigan State University, East Lansing, MI, United States.
Department of Immunology and Infectious Diseases, Harvard T.H. Chen School of Public Health, Boston, MA, United States.

Kwaku Poku Asante (KP)

Kintampo Health Research Centre, Kintampo, Ghana.

Seth Owusu-Agyei (S)

Kintampo Health Research Centre, Kintampo, Ghana.
Disease Control Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.

David Lanar (D)

Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.

Virander Chauhan (V)

Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.

Chetan Chitnis (C)

Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.

Sheetij Dutta (S)

Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.

Evelina Angov (E)

Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.

Benoit Gamain (B)

Unité Biologie Intégrée du Globule Rouge, Laboratoire d'Excellence GR-Ex, UMR_S1134, Inserm, INTS, Université Sorbonne Paris Cité, Université Paris Diderot, Paris, France.

Ross L Coppel (RL)

Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Melbourne, VIC, Australia.

James G Beeson (JG)

Burnet Institute, Melbourne, VIC, Australia.

Linda Reiling (L)

Burnet Institute, Melbourne, VIC, Australia.

Deepak Gaur (D)

Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.

David Cavanagh (D)

Ashworth Laboratories, Centre for Immunity, Infection and Evolution, School of Biological Sciences, Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.

Ben Gyan (B)

Kintampo Health Research Centre, Kintampo, Ghana.
Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Augusto J Nhabomba (AJ)

Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.

Joseph J Campo (JJ)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.

Gemma Moncunill (G)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH